4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-002859
President and CEO sold 20,000 shares at $10.66 ($213,200)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin President and CEO | 2023-01-09 | Sale | −20,000 | $10.66 | $213,200 | 7,740,314 | D |
| Open-market sales · 20,000 sh · avg $10.66 · $213,200 | |||||||
Loading xslF345X03/doc4.xml…